These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 37306912)

  • 21. Emerging role of tumor microenvironment derived exosomes in therapeutic resistance and metastasis through epithelial-to-mesenchymal transition.
    Balaji S; Kim U; Muthukkaruppan V; Vanniarajan A
    Life Sci; 2021 Sep; 280():119750. PubMed ID: 34171378
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Battling Chemoresistance in Cancer: Root Causes and Strategies to Uproot Them.
    Ramos A; Sadeghi S; Tabatabaeian H
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502361
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanisms of Resistance to Chemotherapy in Gastric Cancer.
    Marin JJ; Al-Abdulla R; Lozano E; Briz O; Bujanda L; Banales JM; Macias RI
    Anticancer Agents Med Chem; 2016; 16(3):318-34. PubMed ID: 26234359
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Autocrine mechanisms of cancer chemoresistance.
    Butera G; Pacchiana R; Donadelli M
    Semin Cell Dev Biol; 2018 Jun; 78():3-12. PubMed ID: 28751251
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nanoparticle Delivery of TWIST Small Interfering RNA and Anticancer Drugs: A Therapeutic Approach for Combating Cancer.
    Glackin CA
    Enzymes; 2018; 44():83-101. PubMed ID: 30360816
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Non-coding RNAs as Novel Biomarkers in Cancer Drug Resistance.
    Yang H; Qi C; Li B; Cheng L
    Curr Med Chem; 2022; 29(5):837-848. PubMed ID: 34348605
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exosomal microRNAs and long noncoding RNAs: Novel mediators of drug resistance in lung cancer.
    Taghvimi S; Vakili O; Soltani Fard E; Khatami SH; Karami N; Taheri-Anganeh M; Salehi M; Negahdari B; Ghasemi H; Movahedpour A
    J Cell Physiol; 2022 Apr; 237(4):2095-2106. PubMed ID: 35128660
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance.
    Shapira A; Livney YD; Broxterman HJ; Assaraf YG
    Drug Resist Updat; 2011 Jun; 14(3):150-63. PubMed ID: 21330184
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long non-coding RNA mediated drug resistance in breast cancer.
    Singh D; Assaraf YG; Gacche RN
    Drug Resist Updat; 2022 Jul; 63():100851. PubMed ID: 35810716
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chemoresistance caused by the microenvironment of glioblastoma and the corresponding solutions.
    Zhang X; Ding K; Wang J; Li X; Zhao P
    Biomed Pharmacother; 2019 Jan; 109():39-46. PubMed ID: 30391707
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chemoresistance mechanisms of breast cancer and their countermeasures.
    Ji X; Lu Y; Tian H; Meng X; Wei M; Cho WC
    Biomed Pharmacother; 2019 Jun; 114():108800. PubMed ID: 30921705
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular mechanisms for tumour resistance to chemotherapy.
    Pan ST; Li ZL; He ZX; Qiu JX; Zhou SF
    Clin Exp Pharmacol Physiol; 2016 Aug; 43(8):723-37. PubMed ID: 27097837
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Deconstructing breast cancer cell biology and the mechanisms of multidrug resistance.
    Videira M; Reis RL; Brito MA
    Biochim Biophys Acta; 2014 Dec; 1846(2):312-25. PubMed ID: 25080053
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular Mechanisms of Chemoresistance in Oral Cancer.
    Wang C; Liu XQ; Hou JS; Wang JN; Huang HZ
    Chin J Dent Res; 2016 Mar; 19(1):25-33. PubMed ID: 26981604
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNAs and drug resistance in colorectal cancer with special focus on 5-fluorouracil.
    Pouya FD; Gazouli M; Rasmi Y; Lampropoulou DI; Nemati M
    Mol Biol Rep; 2022 Jun; 49(6):5165-5178. PubMed ID: 35212928
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stem cell programs in cancer initiation, progression, and therapy resistance.
    Huang T; Song X; Xu D; Tiek D; Goenka A; Wu B; Sastry N; Hu B; Cheng SY
    Theranostics; 2020; 10(19):8721-8743. PubMed ID: 32754274
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exosome-transmitted miR-128-3p increase chemosensitivity of oxaliplatin-resistant colorectal cancer.
    Liu T; Zhang X; Du L; Wang Y; Liu X; Tian H; Wang L; Li P; Zhao Y; Duan W; Xie Y; Sun Z; Wang C
    Mol Cancer; 2019 Mar; 18(1):43. PubMed ID: 30890168
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of exosomes and miRNAs in drug-resistance of cancer cells.
    Bach DH; Hong JY; Park HJ; Lee SK
    Int J Cancer; 2017 Jul; 141(2):220-230. PubMed ID: 28240776
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mitochondria and cancer chemoresistance.
    Guerra F; Arbini AA; Moro L
    Biochim Biophys Acta Bioenerg; 2017 Aug; 1858(8):686-699. PubMed ID: 28161329
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cancer associated fibroblast mediated chemoresistance: A paradigm shift in understanding the mechanism of tumor progression.
    Jena BC; Das CK; Bharadwaj D; Mandal M
    Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188416. PubMed ID: 32822826
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.